Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-24

Clinical Trial Update: A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects [Phase 4]

View source ↗

Summary

Phase 4 trial comparing albiglutide with exenatide in healthy subjects with results posted; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albiglutide (albiglutide)
  • EXENATIDE (EXENATIDE)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus | Phase 4 | Status: TERMINATED | Results posted: 2020-08-24